{"id":245927,"date":"2012-03-21T17:53:10","date_gmt":"2012-03-21T17:53:10","guid":{"rendered":"http:\/\/www.eugenesis.com\/wolters-kluwer-health-releases-first-medical-journal-ipadr-app-in-pathology\/"},"modified":"2012-03-21T17:53:10","modified_gmt":"2012-03-21T17:53:10","slug":"wolters-kluwer-health-releases-first-medical-journal-ipadr-app-in-pathology","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/wolters-kluwer-health-releases-first-medical-journal-ipadr-app-in-pathology.php","title":{"rendered":"Wolters Kluwer Health Releases First Medical Journal iPad(r) App in Pathology"},"content":{"rendered":"<p><p>    Newswise  LONDON (March 21, 2012)  Wolters Kluwer Health    announced today the release of an iPad app for the medical    journal, Pathology.    The app provides health care professionals with full mobile    accessibility to the latest research into all aspects of    pathology. Pathology is published by Lippincott Williams & Wilkins    (LWW), part of Wolters Kluwer Health on behalf of the Royal College of Pathologists    of Australasia (RCPA).  <\/p>\n<p>    Pathology for the iPad uses optimized digital technology    to provide a fully portable and enhanced print-like reading    experience. It is the first iPad app available that offers    access to the very latest original scientific research and    reviews into pathology.  <\/p>\n<p>    The RCPA is delighted that the cutting edge research and    review topics published in Pathology will now be    available via an iPad app said Professor Brett Delahunt,    Editor of Pathology. Such convenient and user-friendly    access will allow pathologists to fit journal reading more    easily into their busy schedules. This, in turn will help them    in applying advancements in medicine into their important daily    work, ensuring patients receive the best of care.  <\/p>\n<p>    Were delighted to partner with the Royal College of    Pathologists of Australasia to bring the Pathology    journal iPad app to members offering a dynamic, integrated    experience with their journal, added Karen Abramson, President    and CEO of Wolters Kluwer Health Medical Research.  <\/p>\n<p>    Along with full-text downloads of each issue, the new app    allows the user to:     Share articles via email or social media     Adjust text sizing with \"pinch and zoom\"     View multimedia videos, images, and supplements     Store or delete downloaded issues     Browse issues via Quick View     Scroll quickly through abstract summaries     Receive notifications about new issues     Link to the journal website (www.rcpa-pathologyjournal.com)    for additional reading and    searching archives, etc.  <\/p>\n<p>    The Pathology iPad app is available free of charge from    the App StoreSM. The April 2012 issue is also free for users to    experience the app. Once access controls are applied, future    issues will only be available to subscribers and RCPA fellows.  <\/p>\n<p>    ###  <\/p>\n<p>    About Pathology    Pathology  Official Journal of the Royal College of    Pathologists of Australasia (RCPA) is committed to publishing    peer-reviewed, original articles related to the science of    pathology in its broadest sense, including anatomical    pathology, chemical pathology and biochemistry, cytopathology,    experimental pathology, forensic pathology and morbid anatomy,    genetics, haematology, immunology and immunopathology,    microbiology and molecular pathology.  <\/p>\n<p>    About the Royal College of Pathologists of Australasia    The Royal College of    Pathologists of Australasia (RCPA) has been responsible for    the training and professional development of pathologists for    more than fifty years. It is also responsible for the promotion    of the science and practice of Pathology. The principal object    of the College is: to promote the study of the science and    practice of Pathology in relation to medicine; to encourage    research in pathology and ancillary sciences, to bring together    pathologists for their common benefit and for scientific    discussions and demonstrations; and to disseminate knowledge of    the principles and practice of pathology in relation to    medicine by such means as may be thought fit.  <\/p>\n<p>    About Lippincott Williams & Wilkins    Lippincott Williams & Wilkins (LWW) is a leading    international publisher of trusted content delivered in    innovative ways to practitioners, professionals and students to    learn new skills, stay current on their practice, and make    important decisions to improve patient care and clinical    outcomes.  <\/p>\n<\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/587132\/?sc=rsmn\" title=\"Wolters Kluwer Health Releases First Medical Journal iPad(r) App in Pathology\">Wolters Kluwer Health Releases First Medical Journal iPad(r) App in Pathology<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Newswise LONDON (March 21, 2012) Wolters Kluwer Health announced today the release of an iPad app for the medical journal, Pathology.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/wolters-kluwer-health-releases-first-medical-journal-ipadr-app-in-pathology.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245927","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245927"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245927"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245927\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}